Clinical Trial Update: Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate a neoantigen-loaded dendritic cell vaccine in combination with conventional second-line therapy for colorectal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Conventional second-line therapy
• Neoantigen-loaded dendritic cell vaccine

Snippet

Sponsor: The First Affiliated Hospital of Nanchang University | Conditions: Colorectal Cancer (CRC) | NA | Status: RECRUITING